NORWALK, Conn., Feb. 06, 2017 -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry leading service, today announced that its Board of Directors approved a regular quarterly cash dividend of $0.50 per share. The cash dividend will be paid on March 21, 2017 to holders of record of FactSet’s common stock at the close of business on February 28, 2017.
About FactSet
FactSet delivers the world's best insight and information to investment professionals through superior analytics, service, content, and technology. More than 66,000 users make smarter investment decisions with FactSet's desktop analytics, mobile applications, and comprehensive data feeds. FactSet is also an honoree of Fortune's 100 Best Companies to Work For and a Best Workplace Award recipient in the United Kingdom and France. FactSet is listed on the New York Stock Exchange and NASDAQ (NYSE:FDS) (NASDAQ:FDS). Learn more at www.factset.com and follow on Twitter: www.twitter.com/factset.
FactSet Investor Relations Contact: Rima Hyder 857.265.7523 [email protected] Media Relations Contact: Amy Bowman 203.810.2144 [email protected]


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Italy Fines Apple €98.6 Million Over App Store Dominance
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



